Anthropic has launched Claude for Healthcare, a HIPAA-ready AI platform for hospitals and pharmaceutical companies, days ...
Analysts have recently evaluated Haemonetics and provided 12-month price targets. The average target is $87.45, accompanied ...
New data reveals that just 2.2% of players generate half of all gambling revenue, driving the legislative shift to a licensed ...
The Sensex rose 302 points to close at 83,878, while the Nifty gained 107 points to finish at 25,790, recovering more than 1% ...
Global solar growth is flattening in major markets as oversupply from China and India drives prices down and shifts competition from sheer volume to execution, policy alignment, and system integration ...
Is India’s Job Future Only About AI? LinkedIn’s 2026 report reveals how India’s workforce is evolving beyond tech, and how ...
The current earnings growth consensus for 2026 is no exception. While forecasts indicate roughly 12.5–15% EPS growth, several ...
In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback